AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Provided By GlobeNewswire
Last update: Nov 5, 2024
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Lausanne, Switzerland, November 5, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the quarter ended September 30, 2024, and provided a corporate update.
Read more at globenewswire.com
